TD Waterhouse Canada’s Precision BioSciences DTIL Stock Holding History

TD Waterhouse Canada’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8	Hold	1	–	–	﹤0.01%	2382
2026 Q1	$6	Buy	+1	New	+$5	﹤0.01%	2291

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

TD Waterhouse Canada's DTIL Position: Q2 2026 in Review

TD Waterhouse Canada held its Precision BioSciences (DTIL) position steady in Q2 2026 at 1 share worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

TD Waterhouse Canada first reported a position in DTIL in Q1 2026 and has held it in 2 quarters since. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

TD Waterhouse Canada held 1 share of Precision BioSciences worth $8 as of Q2 2026.
TD Waterhouse Canada left its Precision BioSciences share count unchanged in Q2 2026.
Precision BioSciences made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2382 holding.
TD Waterhouse Canada first reported a position in Precision BioSciences in Q1 2026 and has held it in 2 quarters since.
95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.